Miglitol

• Background:

  An α-glucosidase inhibitor which induces an enhanced and prolonged release of glucagon-like peptide-1, regulating appetite and stabilizing body weight in humans1. Displays anti-atherothrombotic effect by reducing platelet activation2 and raising circulating adiponectin levels3 in patients with type 2 diabetes. Clinically useful antidiabetic agent.

• Conjugation:

  Unconjugated

• Buffer:

  White solid

• Storage Conditions:

  RT